Science Inventory

You are here:

EPA Home » Science Inventory » SETAC: Nonmonotonic dose response curves (NMDRCs) are common after Estrogen or Androgen signaling pathway disruption. Fact or Falderal?

SETAC: Nonmonotonic dose response curves (NMDRCs) are common after Estrogen or Androgen signaling pathway disruption. Fact or Falderal?

Contact

email: CCTE@epa.gov

Contact

https://ecomments.epa.gov/aboutcphea

Citation:

Gray, E. SETAC: Nonmonotonic dose response curves (NMDRCs) are common after Estrogen or Androgen signaling pathway disruption. Fact or Falderal? BIRTH DEFECTS RESEARCH PART A: CLINICAL AND MOLECULAR TERATOLOGY. John Wiley & Sons, Ltd., Indianapolis, IN, , N/A, (2016).

Impact/Purpose:

Publication for focused topic meeting

Description:

This is a small abstract contained within a workshop report for SETAC.

Record Details:

Record Type:DOCUMENT( JOURNAL/ PEER REVIEWED JOURNAL)
Product Published Date:10/20/2016
Record Last Revised:11/27/2017
OMB Category:Other
Record ID: 338493